Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Guardant Health, Inc. stock logo
GH
Guardant Health
$49.54
-1.9%
$45.48
$20.14
$53.42
$6.26B1.442.17 million shs2.41 million shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$48.34
+0.8%
$52.23
$13.47
$72.98
$10.74B2.0223.48 million shs27.29 million shs
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$30.91
-0.8%
$31.97
$21.39
$35.53
$5.10B0.731.86 million shs1.13 million shs
Veracyte, Inc. stock logo
VCYT
Veracyte
$26.34
-4.3%
$28.00
$19.73
$47.32
$2.15B2.07917,767 shs691,394 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Guardant Health, Inc. stock logo
GH
Guardant Health
0.00%-1.20%+4.56%+20.27%+74.78%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
0.00%-3.06%-15.10%+72.94%+130.58%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.00%-6.76%-5.74%-8.52%+12.41%
Veracyte, Inc. stock logo
VCYT
Veracyte
0.00%+0.47%+0.18%-6.84%+27.78%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Guardant Health, Inc. stock logo
GH
Guardant Health
3.7985 of 5 stars
2.51.00.04.43.72.50.6
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.1475 of 5 stars
2.02.00.00.01.83.31.9
Option Care Health, Inc. stock logo
OPCH
Option Care Health
4.3378 of 5 stars
2.44.00.04.32.61.71.9
Veracyte, Inc. stock logo
VCYT
Veracyte
3.751 of 5 stars
3.41.00.04.33.50.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Guardant Health, Inc. stock logo
GH
Guardant Health
3.00
Buy$53.768.52% Upside
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1.92
Reduce$39.58-18.11% Downside
Option Care Health, Inc. stock logo
OPCH
Option Care Health
2.88
Moderate Buy$35.5014.85% Upside
Veracyte, Inc. stock logo
VCYT
Veracyte
2.70
Moderate Buy$40.9055.28% Upside

Current Analyst Ratings Breakdown

Latest VCYT, HIMS, OPCH, and GH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$45.00
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$30.00
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform
6/23/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
6/18/2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$36.00
6/13/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.00
6/11/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$40.00
6/4/2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$61.00 ➝ $65.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$49.00 ➝ $42.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$51.00 ➝ $41.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Guardant Health, Inc. stock logo
GH
Guardant Health
$739.02M8.30N/AN/A($1.13) per share-43.84
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$1.48B7.33$0.35 per share136.24$2.16 per share22.38
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$5.00B1.01$1.63 per share18.94$8.25 per share3.75
Veracyte, Inc. stock logo
VCYT
Veracyte
$445.76M4.63$0.99 per share26.53$15.17 per share1.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Guardant Health, Inc. stock logo
GH
Guardant Health
-$436.37M-$3.39N/AN/AN/A-53.82%N/A-26.77%8/6/2025 (Estimated)
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$126.04M$0.69111.5892.961.769.24%22.75%15.51%8/4/2025 (Estimated)
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$211.82M$1.2422.7524.531.884.12%16.90%7.00%7/30/2025 (Estimated)
Veracyte, Inc. stock logo
VCYT
Veracyte
$24.14M$0.4130.2336.58N/A7.13%6.14%5.60%8/5/2025 (Estimated)

Latest VCYT, HIMS, OPCH, and GH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.17N/AN/AN/A$550.06 millionN/A
7/30/2025Q2 2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$0.40N/AN/AN/A$1.35 billionN/A
5/5/2025Q1 2025
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.12$0.20+$0.08$0.20$535.21 million$586.01 million
4/30/2025Q1 2025
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million
4/29/2025Q1 2025
Option Care Health, Inc. stock logo
OPCH
Option Care Health
$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Option Care Health, Inc. stock logo
OPCH
Option Care Health
N/AN/AN/AN/AN/A
Veracyte, Inc. stock logo
VCYT
Veracyte
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
4.11
3.76
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/A
1.59
1.32
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.82
1.54
1.02
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
5.10
4.78

Institutional Ownership

CompanyInstitutional Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
98.05%
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A

Insider Ownership

CompanyInsider Ownership
Guardant Health, Inc. stock logo
GH
Guardant Health
6.10%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
17.71%
Option Care Health, Inc. stock logo
OPCH
Option Care Health
0.64%
Veracyte, Inc. stock logo
VCYT
Veracyte
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
2,021123.89 million116.33 millionNot Optionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,637223.83 million184.19 millionOptionable
Option Care Health, Inc. stock logo
OPCH
Option Care Health
8,088163.75 million162.70 millionOptionable
Veracyte, Inc. stock logo
VCYT
Veracyte
79078.32 million77.22 millionOptionable

Recent News About These Companies

Veracyte, Inc. (VCYT) - Yahoo Finance
Veracyte (NASDAQ:VCYT) Downgraded by Wall Street Zen to "Hold"

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Guardant Health stock logo

Guardant Health NASDAQ:GH

$49.54 -0.96 (-1.90%)
Closing price 04:00 PM Eastern
Extended Trading
$49.32 -0.21 (-0.43%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$48.34 +0.36 (+0.75%)
Closing price 03:59 PM Eastern
Extended Trading
$48.18 -0.17 (-0.34%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Option Care Health stock logo

Option Care Health NASDAQ:OPCH

$30.91 -0.25 (-0.80%)
As of 04:00 PM Eastern

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Veracyte stock logo

Veracyte NASDAQ:VCYT

$26.34 -1.17 (-4.25%)
Closing price 04:00 PM Eastern
Extended Trading
$26.46 +0.12 (+0.46%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.